Pharmaceutical Research and Manufacturers of America

Registered Principal Details

Business Or Interest:
Research and manufacturing pharmaceuticals organizations.

Lobbying Interests:
All matters affecting the pharmaceuticals and health care industries.

CEO Name:
John Castellani
Regional Director

Contact
LC
Linda Carroll-Shern
55 E Fifth St Ste 1255
St. Paul, MN 55101
(651) 224-4548
(651) 224-4084
LShern@phrma.org

Authorized Lobbyists

Lobbyist Name Exclusive Duties Authorized On Withdrawn On

Lobbying Interests

Legislative Bills/Resolutions

September 2011 Special Session Assembly Bill 13
September 2011 Special Session Assembly Bill 13
Relating to: providing immunity from liability to drug and device manufacturers and sellers under certain circumstances.

Bill Text and History

For
Notification Date
10/18/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
September 2011 Special Session Senate Bill 13
September 2011 Special Session Senate Bill 13
Relating to: providing immunity from liability to drug and device manufacturers and sellers under certain circumstances.

Bill Text and History

For
Notification Date
10/18/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Budget Bill Subjects

Health Services: Medical Assistance and Related Programs
Biennial budget bill treatment of matter relating to
Health Services: Medical Assistance and Related Programs

Notification Date
4/12/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Comments
Medical Assistance funding related to MA prescription drug benefits

Regulation and Licensing
Biennial budget bill treatment of matter relating to
Regulation and Licensing

Notification Date
4/12/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Comments
Related to the proposed expansion of the Pharmacy Scope of Practice

Topics Not Yet Assigned A Bill Or Rule Number

Dual eligible demonstration projects
Development, drafting or introduction of a proposal relating to
Dual eligible demonstration projects

Action Intended To Affect
Legislative matter

Notification Date
11/21/2012
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

State health care exchanges
Development, drafting or introduction of a proposal relating to
State health care exchanges

Action Intended To Affect
Legislative matter

Notification Date
11/21/2012
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

LRB-2890/2 related to immunity from liability to drug and device manufacturers and sellers under certain circumstances
Development, drafting or introduction of a proposal relating to
LRB-2890/2 related to immunity from liability to drug and device manufacturers and sellers under certain circumstances

Action Intended To Affect
Legislative Matter

Notification Date
10/6/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

DHFS plan to move the Medicaid managed care pharmacy benefit to Medicaid fee-for-service
Development, drafting or introduction of a proposal relating to
DHFS plan to move the Medicaid managed care pharmacy benefit to Medicaid fee-for-service

Action Intended To Affect
Legislative Matter

Notification Date
1/1/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Issues related to the discovery, development, detailing, sales and maketing of prescription drugs.
Development, drafting or introduction of a proposal relating to
Issues related to the discovery, development, detailing, sales and maketing of prescription drugs.

Action Intended To Affect
Legislative Matter

Notification Date
1/1/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Resolution to Congress RE: SCHIP reauthorization
Development, drafting or introduction of a proposal relating to
Resolution to Congress RE: SCHIP reauthorization

Action Intended To Affect
Legislative Matter

Notification Date
1/1/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Wholesale licensure of prescription drugs
Development, drafting or introduction of a proposal relating to
Wholesale licensure of prescription drugs

Action Intended To Affect
Legislative Matter

Notification Date
1/1/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Total Lobbying Effort

  2011
January - June
2011
July - December
2012
January - June
2012
July - December
Total
Total Lobbying Expenditures 2011
January - June
$57,840.52
2011
July - December
$25,645.62
2012
January - June
$46,998.91
2012
July - December
$50,594.54
Total $181,079.59
Total Hours Communicating 2011
January - June
35.50
2011
July - December
20.50
2012
January - June
23.50
2012
July - December
7.50
Total 87.00
Total Hours Other 2011
January - June
66.50
2011
July - December
33.50
2012
January - June
70.00
2012
July - December
40.75
Total 210.75

Percent Allocation of Lobbying Effort

Legislative Bills/Resolutions

Relating to: providing immunity from liability to drug and device manufacturers and sellers under certain circumstances.
2011
January - June
2011
July - December
2012
January - June
2012
July - December
Total
2011
January - June
2011
July - December
10%
2012
January - June
2012
July - December
Total 2%
Relating to: providing immunity from liability to drug and device manufacturers and sellers under certain circumstances.
2011
January - June
2011
July - December
2012
January - June
2012
July - December
Total
2011
January - June
2011
July - December
45%
2012
January - June
2012
July - December
Total 8%

Budget Bill Subjects

2011
January - June
2011
July - December
2012
January - June
2012
July - December
Total
2011
January - June
15%
2011
July - December
2012
January - June
2012
July - December
Total 5%
2011
January - June
2011
July - December
2012
January - June
2012
July - December
Total
2011
January - June
60%
2011
July - December
25%
2012
January - June
25%
2012
July - December
13%
Total 35%

Administrative Rulemaking Proceedings

No administrative rulemaking proceedings found.

Topics Not Yet Assigned A Bill Or Rule Number

2011
January - June
2011
July - December
2012
January - June
2012
July - December
Total
2011
January - June
15%
2011
July - December
2012
January - June
12%
2012
July - December
Total 9%
2011
January - June
2011
July - December
2012
January - June
2012
July - December
Total
2011
January - June
2011
July - December
2012
January - June
8%
2012
July - December
Total 3%
2011
January - June
2011
July - December
2012
January - June
2012
July - December
Total
2011
January - June
2011
July - December
2012
January - June
10%
2012
July - December
Total 3%
2011
January - June
2011
July - December
2012
January - June
2012
July - December
Total
2011
January - June
2011
July - December
2012
January - June
2012
July - December
10%
Total 2%
2011
January - June
2011
July - December
2012
January - June
2012
July - December
Total
2011
January - June
2011
July - December
2012
January - June
2012
July - December
20%
Total 3%

Minor Efforts

(Time spent on matters each of which accounted for less than 10% of the organization's lobbying.)

Minor Efforts
2011
January - June
2011
July - December
2012
January - June
2012
July - December
Total
2011
January - June
5%
2011
July - December
10%
2012
January - June
5%
2012
July - December
Total 5%

Other Matters

Includes time spent on:

  • Gubernatorial nominations
  • Matters on which the organization made no lobbying communication

Other Matters
2011
January - June
2011
July - December
2012
January - June
2012
July - December
Total
2011
January - June
5%
2011
July - December
10%
2012
January - June
40%
2012
July - December
57%
Total 25%

Filed Statements of Lobbying Activity and Expenditures